Scarica l'app Stockscreener
250.49
2.82%
6.88
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WST Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
West Pharmaceutical Services Inc Borsa (WST) Ultime notizie
West Pharmaceutical Services (WST): Barclays Lowers Price Target - GuruFocus
Stephens Cuts Price Target on West Pharmaceutical Services to $320 From $350, Maintains Overweight Rating - marketscreener.com
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2025 Earnings Call Transcript - Insider Monkey
West Pharmaceutical Services Q4 Earnings Call Highlights - Yahoo Finance
West Pharmaceutical targets 5%–7% organic revenue growth for 2026 as HVP demand accelerates - MSN
West Pharma forecasts 2026 profit above estimates on strong demand for drug components - 104.1 WIKY
Earnings call transcript: West Pharmaceutical Services Q4 2025 earnings beat expectations - Investing.com Canada
West Pharmaceutical Services (WST) Is Up 5.2% After Strong 2025 Results And 2026 Organic Growth Outlook - Yahoo Finance
West Pharmaceutical Q4 2025 slides: Revenue up 7.5%, EPS exceeds expectations - Investing.com Nigeria
West Pharmaceutical Services (NYSE:WST) Issues Quarterly Earnings Results, Beats Expectations By $0.21 EPS - MarketBeat
West Pharmaceutical Services's (NYSE:WST) Q4 CY2025: Beats On Revenue, Stock Soars - Finviz
WST's Q4 Earnings & Sales Beat, SmartDose Sale by Mid-2026, Stock Up - Finviz
Iron Mountain Projects Double-Digit Growth in 2026 - Investing.com
West Pharmaceutical Q4 2025 slides: Revenue up 7.5%, EPS exceeds expectations By Investing.com - Investing.com India
West Pharmaceutical (WST) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
West Pharmaceutical Services (NYSE:WST) Issues FY 2026 Earnings Guidance - MarketBeat
In the latest conference call, West Pharmaceutical Services Inc executives noted that although demand for GLP-1 drugs is showing strong growth momentum in 2025, the growth pace is expected to slow down in 2026. - Bitget
West Pharmaceutical (WST) Exceeds Market Expectations with Stron - GuruFocus
West Pharmaceutical Services, Inc. $WST Shares Sold by ING Groep NV - MarketBeat
West Pharma (WST) Q4 2025 Earnings Call Transcript - The Globe and Mail
West Pharmaceutical Services Posts Solid Q4 and 2025 Results - TipRanks
West Pharmaceutical (WST) Exceeds Revenue Expectations in Q4 - GuruFocus
West Pharmaceutical Services (WST) Projects FY26 Revenue Range - GuruFocus
Q4 Earnings Update: IRM, USFD, and WST Post Solid Q4 Results - Tokenist
Form 8-K WEST PHARMACEUTICAL SERV For: Feb 12 - StreetInsider
West Pharmaceutical Q4 EPS Beats Estimates; Guides 2026 Sales Growth of 5% to 7% - AlphaStreet News
West Pharmaceutical Services (WST) Tops Q4 Earnings and Revenue Estimates - Yahoo Finance
West Pharmaceutical: Q4 Earnings Snapshot - kare11.com
West Pharmaceutical Servs Q4 Earnings Summary & Key Takeaways - Benzinga
WEST PHARMACEUTICAL SVSC ($WST) Releases Q4 2025 Earnings - Quiver Quantitative
West Pharma shares climb over 5% on strong fourth-quarter results - Investing.com UK
West Pharma shares climb over 5% on strong fourth-quarter results By Investing.com - Investing.com Nigeria
West Pharmaceutical: Q4 Financial Results Overview - Bitget
(WST) West Pharmaceutical Services, Inc. Expects Q1 Adjusted EPS Range $1.65$1.70 - marketscreener.com
West Pharmaceutical Services earnings beat by $0.20, revenue topped estimates - Investing.com Canada
West Pharmaceutical Services’s (NYSE:WST) Q4 CY2025: Beats On Revenue, Stock Soars - Yahoo Finance
(WST) West Pharmaceutical Expects 2026 Net Sales Range $3.22B to $3.28B, vs. FactSet Est of $3.24B - marketscreener.com
West Reports Fourth-Quarter and Full-Year 2025 Results – Company Announcement - Financial Times
Is West Pharmaceutical Services (NYSE:WST) a Pillar In S&P 500 Futures Performance - Kalkine Media
West Pharmaceutical faces earnings test as estimates drift lower By Investing.com - Investing.com Canada
Evaluating West Pharmaceutical Services (WST) Valuation As Earnings And GLP 1 Growth Stay In Focus - Sahm
West Pharmaceutical Services, Inc. (NYSE:WST) Receives Average Rating of "Buy" from Brokerages - MarketBeat
West Pharmaceutical Services Earnings Preview: Analysts Project $793.4M RevenueNews and Statistics - IndexBox
West Pharmaceutical Services Earnings: What To Look For From WST - Finviz
West Pharmaceutical Services Inc (WST)'s Winning Formula: Financ - GuruFocus
Countdown to West Pharmaceutical (WST) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS - Yahoo Finance
Jefferies Adjusts Price Target on West Pharmaceutical Services to $295 From $365, Maintains Buy Rating - marketscreener.com
Rockland Trust Co. Buys 5,087 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
WST Q4 Earnings Preview: Can HVP Momentum Continue to Drive Margins? - TradingView
Envestnet Asset Management Inc. Cuts Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Why The Narrative Around West Pharmaceutical Services (WST) Is Shifting After New Valuation Updates - Yahoo Finance
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory - Insider Monkey
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MSN
West Pharmaceutical Services Unveils “Synchrony S1” Syringe System to Speed Drug Packaging Development - MarketBeat
West Pharmaceutical Services Inc (WST) Trading 5.8% Higher on Fe - GuruFocus
West Pharmaceutical Services stock: Is WST underperforming the healthcare sector? - MSN
0.17%
0.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):